Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Updates in immunotherapy for head and neck cancer
|
Mar 28, 2024 |
Updates in immunotherapy for skin cancer
|
Mar 22, 2024 |
Highlights in colorectal cancer at ASCO GI 2024
|
Mar 08, 2024 |
Targeted therapies for lung cancer at TTLC 2024
|
Mar 01, 2024 |
Updates in invasive lobular carcinoma (ILC)
|
Feb 23, 2024 |
Esophageal and gastric cancer highlights from ASCO GI 2024
|
Feb 16, 2024 |
Key updates at ASCO GU 2024
|
Feb 09, 2024 |
Highlights in bladder and prostate cancer at PROCSA/BLADDR 2023
|
Feb 02, 2024 |
Key updates at ESMO Asia 2023
|
Jan 26, 2024 |
Breast Cancer Sessions: Highlights from SABCS 2023 with Sara Tolaney, Sarah Sammons & Paolo Tarantino
|
Jan 12, 2024 |
Updates in GI cancer at ESMO 2023
|
Jan 05, 2024 |
2023 updates in metastatic colorectal cancer genomic biomarkers
|
Dec 22, 2023 |
Highlights in cancer nursing at UKONS 2023
|
Dec 01, 2023 |
Highlights in gynecologic cancer from ESMO 2023
|
Nov 24, 2023 |
Highlights in breast cancer from ESMO 2023
|
Nov 17, 2023 |
Highlights in lung cancer from ESMO 2023
|
Nov 10, 2023 |
Highlights in GU cancer at ESMO 2023
|
Nov 03, 2023 |
EGFR exon 20 insertions and how to manage patients in the UK
|
Oct 13, 2023 |
Updates in immunotherapy for brain tumors
|
Sep 15, 2023 |
Developments in Radiotherapy for GI Cancer
|
Sep 08, 2023 |
Latest advances in early-stage breast cancer
|
Aug 25, 2023 |
Applications of AI in Oncology
|
Aug 18, 2023 |
Targeted radionuclide therapy in prostate cancer
|
Aug 11, 2023 |
Latest updates in mesothelioma
|
Aug 04, 2023 |
iwCAR-T Session V: Advances in head & neck and CNS cancers
|
Jul 28, 2023 |
Highlights in GI cancer from ESMO WCGIC 2023
|
Jul 21, 2023 |
Updates in immunotherapy for head and neck cancer
|
Jul 14, 2023 |
iwCAR-T session VI: Advances in GI cancers
|
Jul 07, 2023 |
Highlights in bladder cancer at ASCO 2023: NORSE, RAGNAR, and THOR
|
Jun 30, 2023 |
ASCO 2023 Highlights: THOR, INDIGO and ADAURA
|
Jun 23, 2023 |
iwCAR-T Session III: CAR-T clinical advances in lung cancer
|
Jun 16, 2023 |
iwCAR-T Session II: Cell therapies in GU cancers
|
May 25, 2023 |
iwCAR-T Session I: Emerging CARs and future challenges in solid tumors
|
May 19, 2023 |
Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors
|
May 09, 2023 |
Liquid biopsy in lung cancer: precision medicine and MRD
|
Apr 28, 2023 |
St. Gallen highlights: controversies in the axilla
|
Apr 14, 2023 |
Radiotherapy Highlights from ASCO GU 2023 with Sophia Kamran, Himanshu Nagar, and Neha Vapiwala
|
Apr 06, 2023 |
Chemotherapy, post-adjuvant therapy, and clinical trial ethics at St Gallen BCC 2023
|
Mar 31, 2023 |
Key Trials from ASCO GU 2023 with Scott Tagawa, Karie Runcie, and Tanya Dorff
|
Mar 24, 2023 |
Biomarkers, patient selection, and immunotherapy at ESMO Gynae 2023
|
Mar 17, 2023 |
Hot Topics in Renal Cell Carcinoma and Rare Tumors
|
Mar 10, 2023 |
Key data and hot topics in prostate cancer at ASCO GU 2023
|
Mar 03, 2023 |
Hot Topics in Bladder Cancer at ASCO GU 2023
|
Feb 24, 2023 |
Approaches to NSCLC with or without targetable mutations
|
Feb 17, 2023 |
CAR-T in solid tumors: advances and challenges in targeting CLDN18.2, HER2 and STEAP 1
|
Feb 10, 2023 |
ASCO GI 2023: Bile duct cancer updates with Ghassan Abou-Alfa
|
Feb 03, 2023 |
Breast Cancer Sessions: Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons
|
Jan 25, 2023 |
Updates in cervical cancer
|
Jan 20, 2023 |
Resistance to immune checkpoint inhibitors in NSCLC
|
Jan 13, 2023 |
Impact of race on breast cancer outcomes
|
Jan 06, 2023 |
Immunotherapy updates in GI cancer
|
Dec 23, 2022 |
Updates from ESMO Asia 2022
|
Dec 16, 2022 |
Updates in EGFR-mutant NSCLC
|
Dec 02, 2022 |
UKONS 2022: cancer care in the digital age
|
Nov 25, 2022 |
Updates in immunotherapy from SITC 2022
|
Nov 18, 2022 |
Advances in radiotherapy from ASTRO 2022
|
Nov 16, 2022 |
Immunotherapy Updates in Head & Neck Cancer
|
Nov 04, 2022 |
Evolving role of ctDNA in breast cancer
|
Oct 26, 2022 |
Updates in Immuno-Oncology from ITOC 2022
|
Oct 24, 2022 |
ESMO 2022: Updates in Sarcoma
|
Oct 14, 2022 |
GI Cancer Sessions: ESMO Highlights with Geoffrey Ku and Sam Klempner
|
Oct 12, 2022 |
Breast Cancer Sessions: Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja
|
Oct 10, 2022 |
ESMO 2022: Updates in Colorectal Cancer
|
Sep 30, 2022 |
ESMO 2022: Updates in Breast Cancer
|
Sep 26, 2022 |
ESMO 2022 Daily Round-Ups: Day 4
|
Sep 12, 2022 |
ESMO 2022 Daily Round-Ups: Day 3
|
Sep 12, 2022 |
ESMO 2022 Daily Round-Ups: Day 2
|
Sep 11, 2022 |
The Lung Cancer Sessions: Updates from WCLC 2022
|
Sep 02, 2022 |
TILs, Cancer Vaccines & the Future of Cellular Therapies in Melanoma with Allison Betof Warner
|
Aug 26, 2022 |
Updates in lung cancer from WCLC 2022
|
Aug 19, 2022 |
Updates in Checkpoint Inhibitors for Kidney Cancer
|
Aug 12, 2022 |
iwCART Sessions: CAR-T clinical advances in breast and ovarian cancer
|
Aug 05, 2022 |
Clinical Applications of ctDNA in Oncology
|
Jul 29, 2022 |
iwCART Sessions: CAR-T clinical advances in lung cancer
|
Jul 22, 2022 |
ASCO 2022: Updates in Gastrointestinal Cancer
|
Jul 15, 2022 |
ASCO 2022: Updates in Genitourinary Cancer
|
Jul 08, 2022 |
ASCO 2022: Updates in Breast Cancer
|
Jul 01, 2022 |
ASCO 2022: Updates in Lung Cancer
|
Jun 24, 2022 |
iwCAR-T Sessions: emerging CARs & challenges in solid tumors
|
Jun 17, 2022 |
ASCO 2022 Daily Round-Ups: Day 3
|
Jun 05, 2022 |
ASCO 2022 Daily Round-Ups: Day 2
|
Jun 04, 2022 |
ASCO 2022 Daily Round-Ups: Day 1
|
Jun 04, 2022 |
Updates in radiation oncology from ESTRO 2022
|
May 27, 2022 |
Breast Cancer Sessions: Treatment de-escalation in TNBC
|
May 20, 2022 |
Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355
|
May 16, 2022 |
Updates in GI cancers from AACR 2022
|
May 06, 2022 |
Expanding use of artificial intelligence (AI) in oncology
|
Apr 29, 2022 |
The evolving role of nurses amidst global pandemic: perspectives, and highlights from cancer nursing leaders
|
Apr 22, 2022 |
The GU Cancer Sessions: Prostate & kidney cancer at ASCO GU 2022
|
Apr 11, 2022 |
Lung Cancer Screening: Current state and future directions
|
Apr 01, 2022 |
Novel treatment approaches in HR+/HER2- breast cancer
|
Mar 25, 2022 |
New treatment approaches for advanced or metastatic urothelial carcinoma
|
Mar 18, 2022 |
The Breast Cancer Sessions: Highlights from SABCS 2021
|
Mar 11, 2022 |
The GI Cancer Sessions: Highlights from ASCO GI 2022
|
Mar 04, 2022 |
Prostate Cancer Highlights from ASCO GU 2022
|
Feb 25, 2022 |
Updates on HER2-positive breast cancer
|
Feb 15, 2022 |
BTOG 2022: Highlights in lung cancer
|
Feb 11, 2022 |
The multidisciplinary use of ctDNA in gastrointestinal cancers
|
Feb 02, 2022 |
SITC 2021: Updates on the use of cellular therapies in solid tumors
|
Jan 19, 2022 |
Breast Cancer Sessions: Highlights from SABCS 2021 with Lisa Carey & Aleix Prat
|
Jan 14, 2022 |
Immunotherapy updates from SABCS 2021 with Heather McArthur & Kevin Kalinsky
|
Jan 04, 2022 |
The Lung Cancer Sessions: Advances in EGFR-mutated NSCLC
|
Nov 25, 2021 |
ISLB 2021: Current standards and future directions for liquid biopsy
|
Nov 12, 2021 |
Prostate Cancer Highlights from ESMO 2021 with Robert Jones
|
Oct 28, 2021 |
The GU Cancer Sessions: Bladder Highlights from ESMO 2021
|
Oct 19, 2021 |
The Skin Cancer Sessions: Highlights from ASCO 2021
|
Oct 07, 2021 |
The Lung Cancer Sessions: Highlights from ASCO 2021
|
Oct 07, 2021 |
The GI Cancer Sessions: Highlights from ASCO 2021
|
Oct 07, 2021 |
Key clinical trial data in urothelial carcinoma at ASCO 2021
|
Sep 10, 2021 |
Prostate Cancer Highlights from ASCO 2021 with Pedro Barata
|
Aug 23, 2021 |
The Breast Cancer Sessions: Highlights from ASCO 2021
|
Aug 18, 2021 |
The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO 2021
|
Aug 18, 2021 |
ASCO 2021: Immunotherapy updates in lung cancer
|
Aug 04, 2021 |
EAU 2021: updates in testicular cancer
|
Jul 28, 2021 |
Highlights from ESMO WCGIC 2021: VALENTINO, KEYNOTE-811 & BEACON-CRC
|
Jul 15, 2021 |
What’s new? Treating breast cancer with brain metastases
|
Jul 13, 2021 |
Global breast cancer care
|
Jul 13, 2021 |
Latest developments in immunotherapy for patients with melanoma
|
Jul 01, 2021 |
ASCO 2021: PSMA-targeted radionuclide therapy for prostate cancer
|
Jun 25, 2021 |
The Lung Cancer Sessions: Highlights from BTOG 2021
|
Jun 22, 2021 |
ESMO Breast 2021: updates on immunotherapy
|
Jun 10, 2021 |
The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO GU 2021
|
May 14, 2021 |
Sequencing HER2-targeting therapies in the metastatic breast cancer space
|
May 14, 2021 |
Latest news in GU: CAR-T in RCC, updates from IMvigor130, & liquid biopsies in prostate cancer
|
May 13, 2021 |
The GU Sessions: Prostate Cancer Highlights from ASCO GU 2021
|
May 13, 2021 |
BTOG 2021: KRAS targeting and oncogenically-driven lung cancer
|
May 12, 2021 |
The Breast Cancer Sessions: a focus on the St. Gallen Consensus
|
Apr 26, 2021 |
Predictive and prognostic biomarkers in breast cancer
|
Apr 07, 2021 |
The Lung Cancer Sessions: highlights from IASLC WCLC
|
Feb 18, 2021 |
The GI Cancer Sessions: Highlights from ASCO GI 2021
|
Feb 12, 2021 |
The Breast Cancer Sessions: Highlights from SABCS 2020
|
Jan 25, 2021 |
SABCS 2020 highlights: immunotherapy, novel agents & trial updates
|
Jan 08, 2021 |
Key trial updates at SABCS 2020: monarchE, RxPONDER & ASCENT
|
Dec 15, 2020 |
Updates in non-small cell lung cancer from ESMO
|
Nov 03, 2020 |
Highlights from EADO 2020: novel therapies, neoadjuvant approaches & COVID-19
|
Oct 29, 2020 |
The Lung Cancer Sessions: learnings from the ESMO 2020 Science Weekend
|
Oct 14, 2020 |
The ONS/EONS Congress Roundtable Discussion with VJOncology and OncoAlert
|
Sep 10, 2020 |
Prioritizing patients for breast cancer surgery during COVID-19
|
Aug 03, 2020 |
Genotyping in lung cancer and multi-cancer detection
|
Jul 01, 2020 |
Molecular testing for lung cancer in the UK
|
May 13, 2020 |
Living with and beyond cancer: a patient’s quality of life is just as important as survival
|
Feb 04, 2019 |
Advancing immunotherapy for solid tumors
|
Nov 23, 2018 |
Updates in breast cancer: recent clinical trials, immunotherapy, challenges & future treatment outlook
|
Oct 11, 2018 |
Hot topics in oncology: precision medicine, biomarkers & immunotherapy
|
Sep 14, 2018 |
Bladder cancer: advances in the spotlight and what these mean for therapy
|
Aug 16, 2018 |